A commentary on

Alterman M, Nassar M, Rushinek H, Cohen A, Shapira L, Casap N.

The efficacy of a protective protocol for oral and maxillofacial surgery procedures in a COVID-19 pandemic area-results from 1471 patients. Clin Oral Investig 2021; DOI: 10.1007/s00784-021-03809-8.

Commentary

This paper presents the experience of an oral and maxillofacial surgery department in a pandemic region during the first wave of the COVID-19 pandemic.1 Despite limitations and significant methodological flaws, it offers insight into efforts to mitigate the risk of unknown transmission of COVID-19 and precautionary measures taken when performing oral surgery procedures from a period when there was little evidence for recommendations.

During the COVID-19 pandemic, most countries have categorised oral and maxillofacial surgical interventions as 'high-risk aerosol generating procedures'.2 This reflects the routine manipulation of tissues with high viral loads within the oral cavity and oropharynx during procedures, and the routine use of surgical drills or cautery which may cause aerosolisation of fluids.

Transmission of COVID-19 has been reported to be more likely in aerosolised form,3 and the efforts to protect staff and patients described by this paper focused on limiting the possibility of encountering infected patients unknowingly. The authors describe a 'quadruple screening protocol' which involved: several symptom-screening opportunities by telephone and in person; patient temperature screening on attendance; protective personal equipment (PPE) for patients and staff; pre-procedural mouthwashes; and a designated negative-pressure room assigned for positive patients meeting criteria for urgent surgery.1

It is important to recognise that the effectiveness of the measures described by this paper cannot be determined by the methodology employed. Important information, such as the infection prevalence in the population, was not available and the few COVID-19 tests performed were negative (63 patients were tested in total). One member of the surgical team tested positive during the study period, which was attributed to exposure in a non-clinical setting, but no details of this case were provided. It is worth noting that infection was not passed to other members of the team, which the authors attribute to their PPE protocols and early detection by regular staff testing.

Aerosolised transmission of COVID-19 clearly presents an ongoing risk in dental practice, where high-speed air rotors, which aerosolise saliva, are frequently used. Aerosol is produced by most dental procedures and patient interactions, including speaking, coughing and sneezing.4 The transmissibility of particles is greater with smaller particle sizes. The size variances can be described as: splatter (>100 μm), droplets (>5 μm) or droplet nuclei (<5 μm).5 The former are larger, heavier particles that, according to a National Services Scotland technical report, will settle up to ten minutes following cessation of production.6 This is of great relevance to the operational practice of oral surgery departments with regards to fallow time and patient throughput.

The oropharynx is a known source of SARS-CoV-2 in an infected individual.7 However, the risk of transmission, specifically in a dental setting, is dependent on the quantity of virus present in the oral cavity. The quantity and viability of SARS-CoV-2 in the aerosol produced by dental procedures is of great significance. Nonetheless, there is a potential risk of transmission and it is important that proportionate mitigations are implemented. Mitigations can include a combination of environmental and procedural factors including ventilation, PPE, high-volume suction, rubber dam and a fallow period. Detailed summaries on the various mitigations available can be found in a publication by the Scottish Clinical Effectiveness Programme titled Mitigation of aerosol generating procedures in dentistry.5

A recent study by Allison et al. aimed to assess the level of aerosol produced from three common dental procedures: ultrasonic scaling, high-speed air turbine and 3-in-1 syringe.8 Unfortunately, these procedures are uncommon in oral surgery and therefore of limited use in this context. However, a commonly used instrument within the speciality of oral surgery is the oral surgical handpiece. This is different to a traditional air turbine handpiece and is commonly electrically operated at much slower revolutions per minute (RPM) (40,000 RPM). It is therefore likely that an oral surgical handpiece produces splatter and droplets, which can be mitigated with standard infection control precautions, widely adopted in dentistry before the emergence of COVID-19.9

Excess mortality and morbidity are expected consequences during a pandemic which has resulted in stretched healthcare systems and national lockdowns which have limited or delayed access to care.10A final point of interest reported by the authors was a high proportion of patients (53%) admitted for drainage of odontogenic fascial space infections having experienced delayed or failed access to dental care before their infection developing. These examples of escalation to more complex treatment or emergency intervention to remedy preventable complications may become more apparent as services recover and societies return to normal. In the UK, it is estimated that ten million dental appointments have been delayed due to COVID-19.11 In the wider healthcare setting, reduced attendances at emergency departments and fewer cancer diagnoses raise concerns of disease progressing untreated and poorer eventual outcomes. This secondary impact is important to consider as services are restored to pre-pandemic levels.